Table 1. Clinicopathological Correlation of MAML2 Rearrangement in PMECs.
MAML2 rearrangement | |||
Variables | Positive (n = 21) | Negative (n = 21) | P |
Median age [range] | 33 [14–73] | 60 [27–76] | 0.001 |
Gender (M/F) | 13/8 | 12/9 | 1.000 |
Tumor size [range], cm | 3.0 [0.5–6.5] | 3.0 [0.5–10.0] | 0.693 |
TNM stage | |||
I∼IIA | 19 (90.5) | 17 (81.0) | 0.663 |
IIB∼IV | 2 (9.5) | 4 (19.0) | |
LN involvement | |||
Yes | 2 (9.5) | 5 (23.8) | 0.410 |
No | 19 (90.5) | 16 (76.2) | |
Intrathoracic invasion | |||
Yes | 4 (19.0) | 6 (28.6) | 0.719 |
No | 17 (81.0) | 15 (71.4) | |
Pathological grade | |||
Low/Intermediate | 21 (100.0) | 12 (57.1) | 0.001 |
High | 0 (0.0) | 9 (42.9) | |
Recurrence/metastasis | |||
Yes | 2 (9.5) | 7 (33.3) | 0.130 |
No | 19 (90.5) | 14 (66.7) |
Abbreviations: MAML2, mastermind-like gene 2; PMECs, pulmonary mucoepidermoid carcinomas; TNM, tumor-nodal-metastasis; LN, lymph node.